PaQ®, a simple 3-day basal/bolus insulin delivery device, may optimise insulin delivery in type 2 diabetes as determined by continuous glucose monitoring

被引：0
|
作者：
Mazze, R. [1 ]
Strock, E. [1 ]
Mader, J. [2 ]
Lilly, L. [3 ]
Aberer, F. [2 ]
Pieber, T. [2 ]
机构：
[1] Int Diabet Ctr, Minneapolis, MN USA
[2] Graz Univ, A-8010 Graz, Austria
[3] CeQur, Marlborough, MA USA
来源：
DIABETOLOGIA | 2014年 / 57卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1005
引用
收藏
页码：S413 / S413
页数：1
相关论文
共 50 条
  • [41] Assessing Insulin Delivery Device Satisfaction in Patients with Type 1 and Type 2 Diabetes
    Snell-Bergeon, Janet K.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2015, 17 (11) : 759 - 762
  • [42] The Durability of Basal Insulin Affects Day-to-Day Glycemic Variability Assessed by Continuous Glucose Monitoring in Type 2 Diabetes Patients: A Randomized Crossover Trial
    Iuchi, Hiroyuki
    Sakamoto, Masaya
    Matsutani, Daisuke
    Suzuki, Hirofumi
    Horiuchi, Ryuzo
    Utsunomiya, Kazunori
    DIABETES TECHNOLOGY & THERAPEUTICS, 2017, 19 (08) : 457 - 462
  • [43] Variability in Basal Insulin Needs in Young Patients with Type 1 Diabetes Using Continuous Subcutaneous Insulin Infusion and Continuous Glucose Monitoring with Predictive Low Glucose Insulin Suspension
    De Tezanos-Pinto, A.
    Pichott, M.
    Barra, A.
    Avila, A.
    Cassorla, F.
    Codner, E.
    Gaete, X.
    Mericq, V
    Roman, R.
    HORMONE RESEARCH IN PAEDIATRICS, 2019, 92 : 21 - 22
  • [44] Clinical Evaluation of Basal-Bolus Therapy Delivered by the V-Go® Wearable Insulin Delivery Device in Patients with Type 2 Diabetes: A Retrospective Analysis
    Zeidan, Trisha
    Nikkel, Carla
    Dziengelewski, Beth
    Wu, Stephanie
    Chen, Aleda M. H.
    PHARMACY, 2020, 8 (04)
  • [45] CLINICAL AND COST-EFFECTIVENESS OF INSULIN DELIVERY WITH V-GO® DISPOSABLE INSULIN DELIVERY DEVICE VERSUS MULTIPLE DAILY INJECTIONS IN PATIENTS WITH TYPE 2 DIABETES INADEQUATELY CONTROLLED ON BASAL INSULIN
    Lajara, Rosemarie
    Davidson, Jaime A.
    Nikkel, Carla C.
    Morris, Tracy L.
    ENDOCRINE PRACTICE, 2016, 22 (06) : 726 - 735
  • [46] Effects of Basal Doses of Insulin Treatment in Type 1 Diabetes Evaluated by Continuous Glucose Monitoring on Glucose Variability
    Proietti, Adrian E., Sr.
    Daghero, Andrea V., Sr.
    Panei, Nicolas, Sr.
    Scapuzzi, Maria L., Sr.
    Jokiel, Andrea E., Sr.
    Glesias, Maria Laura, Sr.
    Velazquez, Julieta
    Nogueira, Juan P., Sr.
    DIABETES, 2018, 67
  • [47] Continuous Glucose Monitoring in Patients With Type 2 Diabetes Receiving Insulin Injections
    Vigersky, Robert A.
    ANNALS OF INTERNAL MEDICINE, 2018, 168 (07) : 528 - 528
  • [48] Continuous glucose monitoring improved glycaemic control in patients with type 1 diabetes during 52 weeks of insulin pump therapy as well as with basal-bolus insulin regimen
    Soupal, J.
    Flekac, M.
    Petruzelkova, L.
    Skrha, J., Jr.
    Skrha, J.
    Prazny, M.
    DIABETOLOGIA, 2015, 58 : S476 - S476
  • [49] Continuous glucose monitoring accuracy during labor and delivery in pregnant women with insulin-treated diabetes
    Citro, F.
    Bianchi, C.
    Aragona, M.
    Belcari, T.
    Nicoli, F.
    Battini, L.
    Marchetti, P.
    Bertolotto, A.
    DIABETOLOGIA, 2023, 66 (SUPPL 1) : S412 - S412
  • [50] Continuous glucose monitoring among adults with type 2 diabetes receiving noninsulin or basal insulin therapy in primary care
    Shields, Stephen
    Thomas, Roy
    Durham, Joy
    Moran, Joseph
    Clary, Jake
    Ciemins, Elizabeth L.
    SCIENTIFIC REPORTS, 2024, 14 (01):
12345